Numerion Labs is an AI-native company accelerating the discovery of life-saving medicines through the development and use of cutting-edge machine learning algorithms. The company unites computational chemistry, structural biology, and medicinal chemistry to pioneer the next generation of AI-driven drug discovery platforms.
Investors 2
| Date | Name | Website |
| 10.07.2026 | B Capital ... | b.capital/ |
| 10.11.2025 | B Capital ... | bcapgroup.... |
Mentions in press and media 1
| Date | Title | Description |
| 10.03.2026 | Leaps by Bayer’s PJ Amini on exits, epigenetics, AI-driven discovery and his ‘50% rule’ | With the notable exception of Monsanto’s billion-dollar acquisition of Climate Corp more than a decade ago, category-defining exits have proved elusive in agtech, which has returned little capital to date. But could 2026 be the year everyth... |